Actuate Therapeutics IncACTUNASDAQ

Revenue (LTM)

Net Income (LTM)

$-27M

-10.3% YoY

Free Cash Flow

$-22M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Dec 22	Dec 23	Dec 24
Revenue	0	0	0
Gross Profit	0	0	0
Operating Income	-20	-25↓23.6%	-25↓0.7%
Net Income	-20	-25↓22.7%	-27↓10.3%
EBITDA	-20	-24↓21.7%	-25↓3.0%
EPS Diluted	-1.34	-1.65↓23.1%	-3.26↓97.6%

Metric	Dec 22	Dec 23	Dec 24
Cash & Equivalents	20	3↓85.5%	9↑192.1%
Total Current Assets	20	3↓85.4%	9↑207.4%
Total Assets	20	3↓85.4%	9↑211.1%
Total Current Liabilities	4	7↑59.3%	9↑27.2%
Total Liabilities	6	103↑1716.1%	9↓91.0%
Total Equity	15	-100↓771.7%	0↑100.1%
Total Debt	0	0	0
Net Debt	-20	-3↑85.2%	-9↓192.1%

Metric	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-18	-22↓21.5%	-22↓1.0%
Capital Expenditure	0	0	0
Free Cash Flow	-18	-22↓21.5%	-22↓1.0%
Stock-Based Comp	1	0↓35.2%	2↑371.2%
Net Change in Cash	1	-17↓1296.8%	6↑132.5%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance